Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.8)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2013, vol. 22, nr 5, September-October, p. 639–653

Publication type: original article

Language: English

Design, Optimization and Evaluation of a Polymerase Chain Reaction for Detection of Borrelia spp.

Projektowanie, optymalizacja i ocena reakcji łańcuchowej polimerazy w celu wykrywania Borrelia spp.

Angel A. Noda1,A,B,C,D,F, Islay Rodríguez1,A,B,C,E,F, Brian Mondeja1,E,F, Carman Fernández1,E,F

1 Bacteriology and Mycology Department, “Pedro Kourí” Tropical Medicine Institute, Havana, Cuba

Abstract

Background. . Lyme borreliosis and relapsing fever are important zoonotic diseases worldwide and the improvement of diagnostic strategies is a prioritized task considering the morbidity of these diseases in some areas. PcR based methods appear to be of utmost importance because of the high sensitivity and specificity of these assays.
Objectives. To obtain a molecular method based on PcR for the detection of the genus Borrelia infection in different specimens.
Results. Sets of reported primers were evaluated “in silico” and they did not fulfill the proposal parameters. On the other hand, the two new, designed sets of primers were theoretically efficient for Borrelia dNA amplification. PcR procedures with these primers were standardized with borrelial dNA and optimum annealing temperatures, primer concentrations and reaction cycle numbers were determined. The PcR analytical sensitivity was 10 genomes per reaction for each technique. Both PcR were highly specific to different Borrelia species dNA and to samples (sera, cerebrospinal liquids and hard ticks) infected artificially with a Borrelia strain, visualizing the amplification of the expected dNA fragment. No amplification was obtained when other microorganisms were used. 36 human clinical samples were negatives in a preliminary study.
Conclusion. Both sets of primers with their respective PcR protocols showed similar results, which suggest that each one can be used indistinctly in detecting Borrelia spp., mainly in countries where the situation of these diseases are unknown

Key words

Borrelia spp., dNA, polymerase chain reaction, optimization.

Słowa kluczowe

Borrelia spp., dNA, reakcja łańcuchowa polimerazy, optymalizacja.

References (44)

  1. Oshaghi MA, Rafinejad J, Choubdar N, Piazak N, Vatandoost H, Telmadarraiy Z, Mohtarami F, Ravasan NM: discrimination of Relapsing fever Borrelia persica and Borrelia microtti by diagnostic species-specific primers and polymerase chain reaction-restriction fragment length polymorphism. Vect Born Zoon dis 2011, 11, 3.
  2. Schwan TG, Piesman J: Vector interactions and molecular adaptations of Lyme disease and Relapsing fever spirochetes associated with transmission by ticks. emerg Infect dis 2002, 8, 2.
  3. Stanek G, Reiter M: The expanding Lyme Borrelia complex-clinical significance of genomic species? clin Microbiol Infect 2011, 17, 487–493.
  4. Rebaudet S, Parola P: epidemiology of relapsing fever borreliosis in europe. feMS Immunol Med Microbiol 2006, 48, 11–15.
  5. Schwan TG, Raffel SJ, Schrumpf ME, Gill JS, Piesman J: characterization of a Novel Relapsing fever Spirochete in the Midgut, coxal fluid, and Salivary glands of the Bat Tick Carios kelleyi. Vect Born Zoon dis 2009, 9, 643– 647.
  6. Wang G, van Dam AP, Schwartz I, Dankert J: Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. clin Microbiol Rev 1999, 2, 633–653.
  7. Cyr TL, Jenkins MC, Hall RD, Masters EJ, McDonald GA: Improving the specificity of 16S rdNA-based polymerase chain reaction for detecting Borrelia burgdorferi sensu lato-causative agents of human Lyme disease. J Appl Microb 2005, 98, 962–970.
  8. Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, McKenna D, Nadelman RB, Cavaliere LF, Wormser GP: Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. clin Infec dis 2001, 33, 2023–2027.
  9. Lebech AM: Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. http://preview.ncbi.nlm.nih.gov/pubmed/11985118 2002, 105, 1–40.
  10. Mantovani E, Costa IP, Gauditano G, Bonoldi VLN, Higuchi ML, Yoshinari NH: description of Lyme diseaselike syndrome in Brazil. Is it a new tick borne disease or Lyme disease variation? Braz J Med Biol 2007, 40, 4.
  11. Cerar T, Ruzic-Sabljic E, Glinsek U, Zore A, Strle F: comparison of PcR methods and culture for the detection of Borrelia spp. in patients with erythema migrans. clin Microbiol Infect 2008, 14, 653–658.
  12. Gordillo-Pérez G, Vargas M, Solórzano-Santos F, Rivera A, Polaco OJ, Alvarado L: demonstration of Borrelia burgdorferi sensu stricto infection in ticks from the northeast of Mexico. clin Microbiol Infect 2009, 15, 496–598.
  13. Oliveira A, Fonseca AH, Marquez C, Mantovani E, Yoshinari NH: growth, cysts and kinetics of Borrelia garinii (Spirochaetales: Spirochaetacea) in different culture media. Mem Inst Oswaldo cruz 2010, 105, 717–719.
  14. Palacios R, Osorio LE, Giraldo LE, Torres AJ, Philipp MT, Ochoa MT: Positive Igg Western blot for Borrelia burgdorferi in colombia. Mem Inst Oswaldo cruz 1999, 94, 499–503.
  15. Rodríguez I, Fernández C, Sánchez L, Martínez B, Siegrist HH, Lienhard R: Prevalence of antibodies of Borrelia burgdorferi sensu stricto in humans from a cuban village. BRAZ J INfecT dIS 2012, 16, 82–85.
  16. Rodríguez I, Ortega LM, Fernández C, Rodríguez ME, Scheurer C, Lienhard R: Borreliosis de Lyme en cuba. A propósito de nuevos casos. Rev Panam Infect 2009, 11, 37–41.
  17. Raoult D, Ndihokubwayo JB, Tissot-Dupont H, Roux V, Faugere B, Abegbinni R: Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet 1998, 352, 353–358.
  18. Ritcher D, Schlee DB, Matuschka FR: Relapsing fever–Like Spirochetes Infecting european Vector Tick of Lyme disease Agent. emerg Infect dis 2003, 15, 234–242.
  19. Picken RN: Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J clin Microbiol 1992, 30, 99–114.
  20. Brusés BLL, Aguirre H, Gorodner MV, Jorge O: comparación de técnicas de extracción de AdN para la detección de Tripanozoma cruzi mediante la técnica de PcR. UNIVeRSIdAd NAcIONAL deL NORdeSTe. comunicaciones científicas y Tecnológicas 2000.
  21. Gern L, Raiz O, Capiau C, Hauser P, Lobet Y, Simoen E, Voet P, Petre J: Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Immunol Lett 1994, 39, 249–258.
  22. Guy EC, Stanek G: detection of Borrelia burgdorferi in patients with Lyme disease by the polymerase chain reaction. J clin Pathol 1991, 44, 610–611.
  23. Rijpkema S, Golubic D, Molkenboer M, Verbeek-De Kruif N, Schellekens J: Identification of four genomic groups of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in a Lyme borreliosis endemic region of northern croatia. exp Appl Acarol 1996, 20, 23–30.
  24. Humair PF, Douet V, Moran-Cadenas F, Schouls L, Van de Pol I, Gern L: Molecular identification of blood meal source in Ixodes ricinus ticks using 12S rdNA as a genetic marker. J Med entomol 2007, 44, 869–880.
  25. Halos L, Taoufik J, Vial L, Maillard R, Suau A, Menach AL, Boulouis HJ, Vayssier-Taussat M: determination of an efficient and reliable method for dNA extraction from ticks. Vet Res 2004, 35, 709–713.
  26. Postic D, Assous MV, Grimont PAD, Baranton G: diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf(5S)-rrl(23S) intergenic spacer amplicons. Int J Syst Bacteriol 1994, 44, 743–752.
  27. Rosa PA, Hogan D, Schwan TG: Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J clin Microbiol 1991, 29, 524–532.
  28. Lee SH, Vigliotti VS, Vigliotti JS, Jones W, Williams J, Walshon J: early Lyme disease with spirochetemia – diagnosed by dNA sequencing. BMc Res Notes 2010, 3, 273.
  29. Hyndman DL, Mitsuhashi M: PcR primer design. Met Mol Biol 2003, 226, 81–88.
  30. Qiagen: Taq PcR Handbook for standard and specialized PcR applications with minimal optimization. editorial QIAgeN companies 2008, 24 pp.
  31. Wilske B: epidemiology and diagnosis of Lyme borreliosis. An Med 2005 37, 568–579.
  32. Fröhler S, Dieterich C: 3Pd: Rapid design of optimal primers for chromosome conformation capture assays. BMc genomics 2009, 10, 635.
  33. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP: diagnosis of Lyme borreliosis. clin Microbiol Rev 2005, 8, 484–509.
  34. Alka D, Sarin BC, Mittar D, Sehajpal PK: Optimization of 38 kda based PcR assay for detection of Mycobacterium tuberculosis from clinical samples. Ind Jour Tuberc 2003, 50, 209.
  35. Roche: PcR applications manual 2006, 34pp.
  36. Grunenwald H: Methods in Molecular Biology. p90. In Bartlett JMS, Stirling d, The PcR Revolution 2006, Humana Press Inc, Totowa, New Jersey.
  37. Marconi RT, Garon CF: development of Polymerase chain Reaction Primer Sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA Signature Nucleotide Analysis. J clin Microbiol 1992, 25, 2830–2834.
  38. Schmidt BL: PcR in laboratory diagnosis of human Borrelia burgdorferi infections. clin Microbiol Rev 1997, 10, 185–201.
  39. Kaufman AC, Greene EC, McGraw AR: Optimization of polymerase chain reaction for the detection of Borrelia burgdorferi in biologic specimens. J Vet diagn Invest 1993, 5, 548–554.
  40. Sparagano OA, Allsopp MT, Mank RA, Rijpkema SG, Figueroa JV, Jongejan F: Molecular detection of pathogen dNA in ticks (Acari: Ixodidae): a review. exp Appl Acarol 1999, 23, 929–960.
  41. Schaarschmidt D, Oehme R, Kimmig P,, Hesch RD, Englisch S: detection and molecular typing of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks and in different patient samples from southwest germany. eur J epidemiol 2001, 17, 1067–1074.
  42. Chen-Yi C, Jiang BG, Wei L, Qiu-Min Z, Xiao-Ming W, Pan-He Z, Lin Z, Hong Y, Wu-Chun C: Presence of pathogenic Borrelia burgdorferi sensu lato in ticks and rodents in Zhejiang, south-east china. J Med Microb 2008, 57, 980–985.
  43. Morán-Cadenas F, Rais O, Jouda F, Douet V, Humai PF, Moret J, Gern L: Phenology of Ixodes ricinus and infection with Borrelia burgdorferi sensu lato along a Northand South-facing altitudinal gradient on chaumont Mountain, Switzerland. J Med entomol 2007, 44, 683–693.
  44. Assous MV, Wilamowski A: Relapsing fever borreliosis in eurasia forgotten, but certainly not gone! clin Microbiol Infect 2009, 15, 407–414.
© Wroclaw Medical University